Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study is a research paper published in Antimicrobial Agents and Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Center for Advancing Translational Sciences
Grant: UL1TR003015
HHS | NIH | National Center for Advancing Translational Sciences
Grant: KL2TR003016
HHS | National Institutes of Health
Grant: K23AI163368
HHS | National Institutes of Health
Grant: AI145322
NIAID NIH HHS
Grant: R01 AI145322
NIGMS NIH HHS
Grant: T32 GM145443
National Institutes of Health
Grant: 5K23AI163368-05
Immune profiling to stratify Clostridioides difficile infection outcomes
National Institutes of Health
Grant: 1KL2TR003016-01
Institutional Career Development Core
National Institutes of Health
Grant: 5R01AI145322-02
Alanyl-glutamine supplementation of standard treatment for C. difficile infection
National Institutes of Health
Grant: 3UL1TR003015-03S1
The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve Health
FWCI
1.16
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals